Li A - Search Results

1

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma.

Cheng Y, Luo R, Zheng H, Wang B, Liu Y, Liu D, Chen J, Xu W, Li A, Zhu Y. Cheng Y, et al. Among authors: li a. Oncotarget. 2017 Apr 4;8(14):23265-23276. doi: 10.18632/oncotarget.15575. Oncotarget. 2017. PMID: 28423574 Free PMC article.

2

[Gemcitabine in the treatment of relapsed or refractory non-Hodgkin's lymphoma].

Ma S, Sheng X, Luo R, Li A. Ma S, et al. Among authors: li a. Zhonghua Zhong Liu Za Zhi. 2002 Nov;24(6):619-20. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12667341 Chinese.

3

Silencing TRPC1 expression inhibits invasion of CNE2 nasopharyngeal tumor cells.

He B, Liu F, Ruan J, Li A, Chen J, Li R, Shen J, Zheng D, Luo R. He B, et al. Among authors: li a, li r. Oncol Rep. 2012 May;27(5):1548-54. doi: 10.3892/or.2012.1695. Epub 2012 Feb 22. Oncol Rep. 2012. PMID: 22367186

4

Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.

Chen J, Zheng D, Shen J, Ruan J, Li A, Li W, Xie G, Luo X, Zhao P, Zheng H. Chen J, et al. Among authors: li w, li a. Oncol Rep. 2013 May;29(5):1888-94. doi: 10.3892/or.2013.2325. Epub 2013 Mar 5. Oncol Rep. 2013. PMID: 23467769

5

NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma.

Gao S, Li A, Liu F, Chen F, Williams M, Zhang C, Kelley Z, Wu CL, Luo R, Xiao H. Gao S, et al. Among authors: li a. Cancer Cell. 2013 Dec 9;24(6):725-37. doi: 10.1016/j.ccr.2013.11.005. Cancer Cell. 2013. PMID: 24332041 Free PMC article.

6

[Therapeutic effect of sorafenib on portal hypertension: research progress and mechanisms].

Zhu Y, Cheng Y, Li A, Luo R. Zhu Y, et al. Among authors: li a. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):133-6. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24463135 Review. Chinese.

7

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.

Chen F, Li A, Gao S, Hollern D, Williams M, Liu F, VanSickle EA, Andrechek E, Zhang C, Yang C, Luo R, Xiao H. Chen F, et al. Among authors: li a. Cell Death Dis. 2014 May 22;5(5):e1242. doi: 10.1038/cddis.2014.224. Cell Death Dis. 2014. PMID: 24853420 Free PMC article.

8

The true role of mRECIST guideline: does it really estimate viable tumor or merely improve accuracy in hepatocellular carcinoma response evaluation?

Liu Q, Li A, Sun S, Luo R, Chen F. Liu Q, et al. Among authors: li a. J BUON. 2014 Apr-Jun;19(2):398-405. J BUON. 2014. PMID: 24965398 Free article.

9

[Diagnosis and treatment of multiple endocrine neoplasia type 2A: a case report and literature review].

Yu R, Wu Z, Li A, Jin G, Luo R. Yu R, et al. Among authors: li a. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(6):909-12. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24968855 Review. Chinese.

10

TIP30 nuclear translocation negatively regulates EGF-dependent cyclin D1 transcription in human lung adenocarcinoma.

Shuai S, Yan X, Zhang J, Kang S, Chen F, Luo R, Li A. Shuai S, et al. Among authors: li a. Cancer Lett. 2014 Nov 1;354(1):200-9. doi: 10.1016/j.canlet.2014.08.008. Epub 2014 Aug 15. Cancer Lett. 2014. PMID: 25135222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,295 results

Search Page

Filters